Table 1. Histone modifications associated with fragment sequencesa.
| H2A.Z | H3K4me1 | H3K4me2 | H3K27ac | H3K27me3 | H3K79me2 | H3K20me1 | |
| E1 (RPL19) | other | other | liver | liver | other | liver | liver |
| E2 (TVAS5) b | – | – | – | – | – | – | – |
| S1 (FAM161A) | other | – | – | – | other | – | – |
| S2 (COL5A2) | liver | – | – | other | other | other | – |
| S3 (AOX1) | other | – | – | – | other | – | other |
| S4 (LDHA) | – | other | – | other | – | – | liver |
| S5 (TUBA1B) | other | other | liver | other | other | liver | liver |
| S6 (TSPAN3) | – | – | – | – | other | liver | liver |
| S7 (RSL1D1) | – | other | – | other | other | liver | liver |
| S8 (MYST2) | – | other | other | other | liver | liver | liver |
a
“liver” signifies histone modifications associated with fragment in HepG2 cells; “other” signifies histone modifications in cell types other than HepG2.
b
No histone modification data for mitochondrial DNA.